| Ytd | -7.18% | |
| 1y | 53.72% |
| Open | 9.76 | Prev Close | 9.72 | Low | 9.56 | High | 9.79 | Mkt Cap | 1.31B |
| Vol | 91.59K | Avg Vol | 477.78K | EPS | -1.99 | P/E | -4.90 | Forward P/E | -5.07 |
| Beta | 1.33 | Short Ratio | 13.12 | Inst. Own | 79.60% | Dividend | N/A | Div Yield | N/A |
| Ex Div Date | N/A | Earning | 08-13 | 50-d Avg | 9.58 | 200-d Avg | 10.06 | 1yr Est | 17.87 |
IMTX News
Shares of Immatics N.V. (NASDAQ: IMTX - Get Free Report) have been assigned a consensus recommendati
Houston, Texas and Tuebingen, Germany, July 17, 2026 - Immatics N. V. (NASDAQ: IMTX, "Immatics" or t
Immatics is evolving into a PRAME-focused oncology platform with three monetization paths, not just
One-time infusion of anzu-cel (anzutresgene autoleucel, IMA203) PRAME cell therapy induced rapid, de
IMA401 achieved deep and durable responses in various indications, including melanoma and head and n
One-time infusion of IMA203CD8 PRAME cell therapy in the ongoing Phase 1 dose escalation/dose expans
Immatics (IMTX) came out with a quarterly loss of $0.5 per share versus the Zacks Consensus Estimate
SUPRAME Phase 3 interim and final analysis for PRAME cell therapy, anzu-cel, expected to be triggere
Immatics (IMTX) has been upgraded to a Zacks Rank #2 (Buy), reflecting growing optimism about the co
Houston, Texas and Tuebingen, Germany, April 21, 2026 - Immatics N. V. (NASDAQ: IMTX, "Immatics" or
Individual experimental treatment attempt at Hopp Children's Cancer Center Heidelberg (KiTZ) and Hei
SG Americas Securities LLC acquired a new stake in shares of Immatics N.V. (NASDAQ: IMTX) in the fou
Shares of Immatics N.V. (NASDAQ: IMTX - Get Free Report) have earned a consensus recommendation of "
Immatics (IMTX) remains a speculative Buy, driven by progress with anzu-cel in 2L melanoma and a rob
Immatics N.V. (NASDAQ: IMTX - Get Free Report)'s share price traded down 5% on Friday. The stock tra
Shares of Immatics N.V. (NASDAQ: IMTX - Get Free Report) have been given an average recommendation o
On Wednesday, 807 companies reached new 52-week lows.
During Tuesday's session, 454 stocks hit new 52-week lows.
On Monday, 671 companies achieved new lows for the year.
On Friday, 368 stocks hit new 52-week lows.
On Wednesday, 348 companies hit new 52-week lows.
During Tuesday's trading, 505 companies set new 52-week lows.
On Friday, 313 companies hit new 52-week lows.
During Monday's session, 291 companies made new 52-week lows. Also check out this: Insid
Wednesday morning saw 162 companies set new 52-week highs.